Archean Chemical Industries
Market cap ₹5,382 Cr
- P/E
- 53.69
- Day range
- ₹432.85 – ₹439.30
- 52-week range
- ₹413.80 – ₹639.80
- Volume
- 80,627
- Open
- ₹437.90
- Prev close
- ₹439.50
Latest results · Q2 FY27(consolidated)Revenue ₹297 Cr+27.5%Profit ₹31 Cr+7.9%Margin 10.5%YoY vs the same quarter last year
No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.
ACI in NSE indices and F&O
Research profile
Composite 37 / 100Factor percentiles
Derived metrics
- Earn. yield
- 1.9%
- Graham no.
- ₹166.44
- vs Graham
- -61.8%
- ROE ÷ P/B
- 1.9%
- 12-1 mom.
- -24.1%
- Return / vol
- -0.95
- Magic Formula
- #564
- Piotroski
- 2/6
- FCF yield
- -4.5%
- PEG
- 6.80
Appears in 7 scans
Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.
Peer comparison
All 44 in Chemicals| Company | M-cap | P/E | P/B | ROE | ROCE | OPM | D/E | Sales YoY |
|---|---|---|---|---|---|---|---|---|
| Solar IndustriesSOLARINDS | ₹1.68 L Cr | 74.04 | 22.19 | 32.5% | 38.0% | 29.0% | 0.23 | +69.0% |
| Pidilite IndustriesPIDILITIND | ₹1.56 L Cr | 58.12 | 14.05 | 24.0% | 31.0% | 20.0% | 0.03 | +20.9% |
| SRF LtdSRF | ₹72,471 Cr | 31.75 | 4.80 | 13.8% | 15.0% | 19.0% | 0.35 | +34.7% |
| Linde IndiaLINDEINDIA | ₹58,548 Cr | 118.46 | 13.42 | 13.6% | 18.0% | 32.0% | 0.23 | +12.3% |
| Coromandel InternationalCOROMANDEL | ₹57,701 Cr | 37.01 | 4.30 | 16.1% | 22.0% | 9.0% | 0.12 | +6.6% |
| Gujarat FluorochemicalsFLUOROCHEM | ₹52,952 Cr | 78.39 | 6.17 | 7.6% | 10.0% | 27.0% | 0.28 | +45.5% |
| Navin Fluorine InternationalNAVINFLUOR | ₹52,759 Cr | 57.95 | 11.37 | 20.1% | 21.0% | 34.0% | 0.28 | +57.1% |
| Archean Chemical IndustriesACI | ₹5,382 Cr | 53.69 | 2.86 | 5.5% | 7.0% | 24.0% | 0.28 | +27.5% |
| Sector median | ₹13,505 Cr | 31.75 | 2.86 | 9.9% | 12.0% | 15.7% | 0.27 | +21.5% |
Sector as classified in the tracked universe; medians use every tracked Chemicals company, and P/E only profitable ones. Tinted figures beat the median.
Latest news
Updated 8h agoHeadlines about Archean Chemical Industries from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.
Key metrics
- P/E (TTM)
- 53.9
- EPS (TTM)
- ₹7.89
- Price / Book
- 2.74
- ROE (FY26)
- 5.5%
- ROCE (latest year)
- 7%
- Dividend yield
- 0.57%
Moving averages (NSE)
- 20-day
- ₹444.66
- Price below
- 50-day
- ₹463.15
- Price below
- 200-day
- ₹532.04
- Price below
Charts & trends
From company filings. Amounts in ₹ crore.
Revenue, profit & margin - quarterly
₹ crore; a loss shows red. Operating margin below, same periods.
- Revenue
- Net profit
Operating margin
Who owns the company
% of equity by quarter, latest Sept 2026
- Promoter
- DII
- Public
- FII
Cash flows
Where cash came from and went, by fiscal year (₹ crore)
- Operating
- Investing
- Financing
- Free cash flow
Return on equity
Net profit over shareholders' equity, by fiscal year
Equity vs debt
Shareholders' equity against borrowings (₹ crore); the ratio below, same years.
- Equity
- Debt
Debt to equity
Dividends per share
₹ by fiscal year of the ex-date; the latest year runs to date.
Financial statements
| Line item | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 413 | 284 | 213 | 240 | 242 | 346 | 292 | 233 | 255 | 301 | 327 | 297 |
| YoY Sales growth | — | -26 | -38 | -17 | -41 | — | — | -3 | — | -13 | — | — |
| Expenses | 267 | 197 | 141 | 166 | 162 | 257 | 214 | 171 | 200 | 257 | 260 | 227 |
| Operating Profit | 145 | 87 | 71 | 75 | 80 | 88 | 78 | 63 | 54 | 44 | 67 | 70 |
| OPM % | 35% | 31% | 33% | 31% | 33% | 26% | 27% | 27% | 21% | 15% | 21% | 24% |
| Other Income | 9 | 12 | 10 | -29 | 9 | 8 | 8 | 6 | 7 | 5 | 6 | 4 |
| Interest | 2 | 2 | 2 | 3 | 3 | 0 | 5 | 6 | 4 | 10 | 5 | 5 |
| Depreciation | 18 | 18 | 19 | 19 | 20 | 21 | 23 | 24 | 24 | 23 | 23 | 24 |
| Profit before tax | 135 | 80 | 61 | 23 | 66 | 75 | 58 | 40 | 33 | 16 | 44 | 46 |
| Tax % | 25% | 28% | 26% | 31% | 27% | 28% | 31% | 27% | 28% | 23% | 31% | 32% |
| Net Profit | 102 | 58 | 45 | 16 | 48 | 54 | 40 | 29 | 24 | 12 | 30 | 31 |
| EPS in Rs | ₹8.23 | ₹4.67 | ₹3.64 | ₹1.28 | ₹3.89 | ₹4.34 | ₹3.26 | ₹2.36 | ₹1.91 | ₹1.09 | ₹2.49 | ₹2.60 |
From company filings, updated 19 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.
Working-capital cycle
-6 days since Mar 2022
+691 days since Mar 2024
+182 days since Mar 2024
+617 days since Mar 2022
-38 days since Mar 2022
Strengths, risks & growth
Archean Chemical Industries Limited is India's largest exporter of bromine and industrial salt in Fiscal 2021. The company is the leading specialty marine chemical manufacturer in India and is focused on producing and exporting bromine, industrial salt, and sulphate of potash to customers around the world. [1]
Strengths
- Company has been maintaining a healthy dividend payout of 21.1%
- Company's working capital requirements have reduced from 49.5 days to 10.8 days
Risks
- Company has a low return on equity of 11.0% over last 3 years.
Compounded Sales Growth
- 10 Years
- —
- 5 Years
- —
- 3 Years
- -9%
- TTM
- +6%
Compounded Profit Growth
- 10 Years
- —
- 5 Years
- —
- 3 Years
- -35%
- TTM
- -42%
Stock Price CAGR
- 10 Years
- —
- 5 Years
- —
- 3 Years
- -6%
- 1 Year
- -23%
Return on Equity
- 10 Years
- —
- 5 Years
- +18%
- 3 Years
- +11%
- Last Year
- +5%
Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.
Shareholding pattern
| Holder | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 | Change |
|---|---|---|---|---|---|
| Promoter | 53.43% | 53.43% | 53.43% | 53.43% | 0.00 pp |
| FII | 11.08% | 11.09% | 11.00% | 10.40% | -0.60 pp |
| DII | 25.26% | 25.83% | 24.18% | 21.34% | -2.84 pp |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00 pp |
| Public | 10.24% | 9.67% | 11.40% | 14.83% | +3.43 pp |
Filed with NSE for Sept 2026: promoters 53.43%, public 46.57%
Analysts & fund holdings
Who holds the shares, quarter by quarter
Mutual funds 15.33% (-0.82 pp)- Promoters53.4%
- Foreign institutions10.4%
- Mutual funds15.3%
- Insurance2.0%
- Other domestic institutions4.0%
- Retail11.0%
- Others3.9%
| Fund | % of company | % of fund | 3-month change |
|---|---|---|---|
| SBI Small Cap Fund | 3.35% | 0.45% | -0.13 pp |
| HDFC Manufacturing Fund | 2.58% | 1.45% | +0.51 pp |
| DSP Small Cap Fund | 2.35% | 0.63% | -0.12 pp |
| HDFC Multi Cap Fund | 1.45% | 0.42% | -0.04 pp |
| Nippon India Small Cap Fund | 1.11% | 0.08% | -0.01 pp |
Scorecard
- Performance
- Low
- Valuation
- High
- Growth
- Low
- Profitability
- High
- Entry point
- Good
- Red flags
- Low
Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.
Risk & trend
From 292 daily sessions to 18 Nov 2026.
Risk
- Volatility (1Y)
- 32.6%
- Downside volatility
- 32.6%
- Worst 5% of days
- 3.5%
- Average of that tail
- 4.7%
- Max drawdown (1Y)
- 41.8%
- Below its peak
- 39.1%
Against the market
- Beta vs Nifty 50
- 0.28
- Correlation
- 0.12
- Relative strength (3M)
- -19.3%
- ATR (14)
- 3.8%
Return
- Return 1M
- -8.9%
- Return 3M
- -15.4%
- Return 6M
- -19.2%
- Return 1Y
- -30.9%
- vs 200-day average
- -18.1%
Momentum
- RSI (14)
- 43.5
- MACD histogram
- 1.41
- Stochastic %K
- 43.3
- ADX (14)
- 13.1
- +DI / −DI
- 25.7 / 19.3
- Money flow index
- 62.7
Participation
- Delivery (20d avg)
- 49.6%
- vs its 60-day baseline
- -3.3 pts
- Volume vs 20-day
- -0.4σ
- Close vs day's VWAP
- -0.1%
- 52-week position
- 7 / 100
These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.
Financial quality
From consolidated statements to 30 Sept 2026.
Piotroski F-Score
2 of 6 tested
- Return on assets positive — passed
- Operating cash flow positive — not testableno cash flow statement for this period
- Return on assets improving — failed
- Cash flow exceeds profit — not testableneeds cash flow and profit against assets
- Debt to assets falling — failed
- Current ratio improving — failed
- No new equity issued — not testableno share count is collected, and financing cash flow mixes equity with debt
- Operating margin improving — failed
- Asset turnover improving — passed
- Free cash flow
- -₹243 Cr
- FCF yield
- -4.5%
- Cash conversion
- 1.32
- Accruals ratio
- -0.013
- Net debt
- ₹503 Cr
- Net debt / equity
- 0.26
- EV / sales
- 4.99
- PEG
- 6.80
- Capex intensity
- 35.4%
- Revenue CAGR
- 27.5%
- Profit CAGR
- 7.9%
Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.
Insider trades
| Person | Type | Shares | Value | Disclosed |
|---|---|---|---|---|
Rajeev Kumar Employees/Designated Employees · ESOP | Buy | 6,142 | ₹12,284 | 17 Nov 2025 |
Disclosures filed with NSE under SEBI (Prohibition of Insider Trading) Regulations. Pledges and releases are not trades and are not counted above.
Corporate actions
- dividend₹2.50
Dividend - Rs 2.50 Per Share
5 Jun 2026ex-date - dividend₹3.00
Dividend - Rs 3 Per Share
26 May 2025ex-date - dividendNot available — not reported in this filing
Dividend - Re 1 Per Share
21 Jun 2024ex-date - dividendNot available — not reported in this filing
Interim Dividend - Re 1 Per Share
14 Feb 2024ex-date - dividendNot available — not reported in this filing
Interim Dividend - Re 1 Per Share
17 Nov 2023ex-date - dividend₹2.50
Dividend - Rs 2.50 Per Share
21 Jul 2023ex-date
Company announcements
Credit Rating
Archean Chemical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the Un-Audited ....
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 15, 2026 for Chemikas Speciality LLP
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 15, 2026 for Chemikas Speciality LLP
Compliance certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 23, 2026 for Chemikas Speciality LLP
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2026 for Chemikas Speciality LLP
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Fund
Earnings call Transcript
Earnings Call Recording
Investor Presentation
Newspaper Publication of Financial Result
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 31, 2026 for Chemikas Speciality LLP
Please find enclosed the Board Meeting Outcome - 30.07.2026 along with the Unaudited Financial Results for the quarter ended June 30, 2026.
Filed with BSE (scrip 543657); the last 45 days. Documents open at bseindia.com.
Documents
Earnings calls
- Nov 2026TranscriptSlidesRecording
- Aug 2026TranscriptSlides
- May 2026TranscriptSlidesRecording
- Feb 2026TranscriptSlidesRecording
- Nov 2025TranscriptSlidesRecording
- Aug 2025TranscriptSlidesRecording
Credit ratings
- Rating update · 21 Oct from crisil
- Rating update · 17 Sep 2025 from crisil
- Rating update · 5 Jul 2024 from crisil
- Rating update · 30 Jun 2023 from crisil
- Rating update · 3 Mar 2023 from icra
- Rating update · 4 Mar 2022 from icra
Documents open at BSE or the rating agency that issued them.
Sourced from the company's NSE XBRL filing dated 30 Oct 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.
Archean Chemical Industries: common questions
Answered from the figures on this page.